Loading
รศ.ดร. ธงชัย ประฏิภาณวัตร

รศ.ดร. ธงชัย ประฏิภาณวัตร

ภาควิชาอายุรศาสตร์,
คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น
15136541200: H-INDEX 3
35479548600: H-INDEX 21
6506635362: H-INDEX 2

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Group A beta-hemolytic streptococcal meningitis in adults. Chotmongkol, V
Prathipanawatra, T
Rojviroj, S
1989
2. Unusual manifestation in a case of nocardial meningitis. Chotmongkol, V.
Prathipanawatra, T.
Tiamkao, S.
1993
3. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. Cusi, K.A.
Pendergrass, M.L.
Pratipanawatr, T.
2000
4. Regulation of MAP kinase pathway activity in vivo in human skeletal muscle Osman, AA
Pendergrass, M
Koval, J
Maezono, K
Cusi, K
Pratipanawatr, T
Mandarino, LJ
2000
5. Effect of a chronic elevation in plasma free fatty acids on insulin secretion and action in non-diabetic offspring with a strong family history of T2DM S Kashyap
R Belfort
T Pratipanawatr
R Berria
W Pratipanawatr
M Bajaj
L Mandarino
R Defronzo
K Cusi
2001
6. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes KJ Cusi
T Pratipanawatr
J Koval
R Printz
H Ardehali
DK Granner
RA DeFronzo
LJ Mandarino
2001
7. Insulin-like growth factor-I (IGF-I) exerts less of an effect of FFA metabolism than insulin (INS) T Pratipanawatr
W Pratipanawatr
R Berria
M Bajaj
K Cusi
S Kashyap
R Aguiar
R Defronzo
2001
8. Insulin-stimulated insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation is decreased in normal glucose tolerant subjects with a strong family history of type 2 diabetes mellitus W Pratipanawatr
T Pratipanawatr
K Cusi
R Berria
J Adams
CY Christ
CP Jenkinson
RA Defronzo
LJ Mandarino
2001
9. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis Pratipanawatr, T.
Kumar, V.
Cusi, K.A.
2001
10. Relationship between insulin stimulation of insulin receptor tyrosine phosphorylation and glucose disposal in human skeletal muscle C Jenkinson
K Maezono
LJ Mandarino
T Pratipanawatr
K Cusi
ML Pendergrass
J Koval
RA Defronzo
2001
11. Skeletal Muscle Insulin Resistance in Normoglycemic Subjects with a Strong Family History of Type 2 Diabetes is Associated with Decreased Insulin-Stimulated Insulin Receptor Substrate-1 Tyrosine Phosphorylation W Pratipanawatr
T Pratipanawatr
K Cusi
R Berria
JM Adams
CP Jenkinson
K Maezono
RA DeFronzo
LJ Mandarino
2001
12. Splanchnic glucose uptake (SGU) in type 2 diabetes M Bajaj
R Berria
T Pratipanawatr
S Kashyap
W Pratipanawatr
L Mandarino
K Cusi
RA Defronzo
2001
13. Chronic elevation in plasma free fatty acids impairs insulin secretion in non-diabetic offspring with a strong family history of T2DM S Kashyap
R Belfort
T Pratipanawatr
R Berria
W Pratipanawatr
M Bajaj
L Mandarino
R Defronzo
K Cusi
2002
14. Chronic physiologic hyperinsulinemia reduces insulin action in skeletal muscle by impairing glucose phosphorylation K Cusi
G Nucci
T Pratipanawatr
R Pipek
C Cobelli
R Defronzo
2002
15. Decreased Akt expression in muscle from patients with type 2 diabetes mellitus is improved by exercise training CY Christ
T Pratipanawatr
R Belfort
S Kashyap
LJ Mandarino
2002
16. Dose-response effects of an acute elevation in plasma free fatty acids on insulin sensitivity in healthy subjects R Belfort
S Kashyap
K Wirfel
T Pratipanawatr
R Berria
W Pratipanawatr
L Mandarino
R Defronzo
K Cusi
2002
17. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects. T Pratipanawatr
W Pratipanawatr
C Rosen
R Berria
M Bajaj
K Cusi
L Mandarino
S Kashyap
R Belfort
RA DeFronzo
2002
18. Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects NA Lee
M Matsuda
P Bressler
T Pratipanawatr
L Glass
LJ Mandarino
RA DeFronzo
2002
19. Effect of pioglitazone on splanchnic glucose uptake, endogenous glucose production, and hepatic fat content in type 2 diabetes mellitus (T2DM) M Bajaj
S Suraamornkul
T Pratipanawatr
LJ Hardies
L Glass
Y Miyazaki
W Pratipanawatr
E Cersosimo
R Defronzo
2002
20. Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans Pratipanawatr, T.
Cusi, K.A.
2002
21. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes. M Bajaj
T Pratipanawatr
R Berria
W Pratipanawatr
S Kashyap
K Cusi
L Mandarino
RA DeFronzo
2002
22. Free fatty acids reduce splanchnic glucose uptake in patients, with type 2 diabetes mellitus M Bajaj
T Pratipanawatr
S Suraamornkul
R Berria
W Pratipanawatr
S Kashyap
R Belfort
K Cusi
L Mandarino
RA Defronzo
2002
23. Intensive insulin therapy does not improve early insulin signaling defects in patients with type 2 diabetes K Cusi
T Pratipanawatr
W Pratipanawatr
J Finlayson
P Ngo
R Defronzo
L Mandarino
2002
24. Kinetics of Akt activation by insulin in human skeletal muscle JM Adams
T Pratipanawatr
LJ Mandarino
2002
25. Muscle contraction increases insulin-dependent Akt serine phosphorylation CY Christ
R Berria
T Pratipanawatr
R Belfort
S Kashyap
RA Defronzo
LJ Mandarino
2002
26. Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes. T Pratipanawatr
K Cusi
P Ngo
W Pratipanawatr
LJ Mandarino
RA DeFronzo
2002
27. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. S Kashyap
R Belfort
A Gastaldelli
T Pratipanawatr
R Berria
W Pratipanawatr
M Bajaj
L Mandarino
R DeFronzo
K Cusi
2003
28. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action Christ-Roberts, CY
Pratipanawatr, T
Pratipanawatr, W
Berria, R
Belfort, R
Mandarino, LJ
2003
29. Intramyocellular lipid (IMCL) is not associtated with insulin resistance in Asian (Thai) type 2 diabetic subjects T Pratipanawatr
E Mairiang
R Chotmongkol
2003
30. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Pratipanawatr, T. 2003
31. Seizures in nonketotic hyperglycaemia T Pratipanawatr
S Tiamkao
B Nitinavakarn
V Chotmongkol
S Jitpimolmard
2003
32. The synergistic effect of exercise on insulin stimulation of glucose disposal (Rd) is accompanied by a synergistic increase in IRS-1 associated PI 3-kinase (PI3K) activity C Christ-Roberts
T Pratipanawatr
W Pratipanawatr
R Berria
R Belfort
L Mandarino
2003
33. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans Adams, JM
Pratipanawatr, T
Berria, R
Wang, E
DeFronzo, RA
Sullards, MC
Mandarino, LJ
2004
34. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. M Bajaj
S Suraamornkul
P Piper
LJ Hardies
L Glass
E Cersosimo
T Pratipanawatr
Y Miyazaki
RA Defronzo
2004
35. Effect of rosiglitazone on insulin sensitivity, liver fat content C-reactive protein and plasma adiponectin in patients with Thai type 2 diabetic subjects T Pratipanawatr
E Mailaing
W Pratipanawat
2004
36. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects Christ-Roberts, CY
Pratipanawatr, T
Pratipanawatr, W
Berria, R
Belfort, R
Kashyap, S
Mandarino, LJ
2004
37. Plasma C-reactive protein lowering effect of rosiglitazone associated with improving glycemic control T Pratipanawatr
R Chotmongkol
S Kanhasura
W Pratipanawatr
2004
38. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients Bajaj, M
Suraamornkul, S
Hardies, LJ
Pratipanawatr, T
DeFronzo, RA
2004
39. Updated Treatment for Osteoporosis Chatlert Pongchaiyakul
Choowong Pongchaiyakul
Thongchai Pratipanawatr
2004
40. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Pratipanawatr, T.
Cusi, K.A.
2005
41. Excessive activation of the IkB/NFkB inflammatory pathway in skeletal muscle from subjects with type 2 diabetes mellitus (T2DM) A Sriwijitkamol
CY Christ-Roberts
R Berria
T Pratipanawatr
RA Defronzo
LJ Mandarino
N Musi
2005
42. Prevalence of dyslipidemia in rural Thai adults: An epidemiologic study in Khon Kaen province Pongchaiyakul, C
Pongchaiyakul, C
Pratipanawatr, T
2005
43. IDF metabolic syndrome definition and Thai obesity subjects Thongchai Pratipanawatr
Nopawan Kittivat
2006
44. Increased collagen content in insulin-resistant skeletal muscle Berria, R
Wang, L
Richardson, DK
Finlayson, J
Belfort, R
Pratipanawatr, T
De Filippis, EA
Kashyap, S
Mandarino, LJ
2006
45. Myasthenia gravis accompanied with hypokalemic periodic paralysis Sawanyawisuth, K
Tiamkao, S
Pratipanawatr, T
2006
46. Reduced skeletal muscle inhibitor of κBβ content is associated with insulin resistance in subjects with type 2 diabetes: Reversal by exercise training Sriwijitkamol, A
Christ-Roberts, C
Berria, R
Eagan, P
Pratipanawatr, T
DeFronzo, RA
Mandarino, LJ
Musi, N
2006
47. Reduced skeletal muscle inhibitor of kappa B beta content is associated with insulin resistance in subjects with type 2 diabetes: Reversal by exercise training - Reversal by exercise training A Sriwijitkamol
C Christ-Roberts
R Berria
P Eagan
T Pratipanawatr
RA DeFronzo
LJ Mandarino
N Musi
2006
48. Thailand Diabetes Registry Project: Current status of dyslipidemia in Thai diabetic patients Pratipanawatr, T
Rawdaree, P
Chetthakul, T
Bunnag, P
Ngarmukos, C
Benjasuratwong, Y
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Krittiyawong, S
Mongkolsomlit, S
Komoltri, C
2006
49. Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage. Kosachunhanun, N.
Mongkolsomlit, S.
Rawdaree, P.
Plengvidhya, N.
Leelawatana, R.
Pratipanawatr, T.
Chetthakul, T.
2006
50. Thailand Diabetes Registry Project: Prevalence and risk factors associated with lower extremity amputation in Thai diabetics Krittiyawong, S
Ngarmukos, C
Benjasuratwong, Y
Rawdaree, P
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Pratipanawatr, T
Chetthakul, T
Mongkolsomlit, S
Bunnag, P
2006
51. Thailand Diabetes Registry Project: Prevalence and risk factors of stroke in Thai diabetic patients Plengvidhya, N
Leelawatana, R
Pratipanawatr, T
Deerochanawong, C
Krittiyawong, S
Bunnag, P
Kosachunhanun, N
Suwanwalaikorn, S
Benjasuratwong, Y
Chetthakul, T
Ngarmukos, C
Vannasaeng, S
Mongkolsomlit, S
Komoltri, C
Rawdaree, P
2006
52. Thailand Diabetes Registry Project: Prevalence, characteristics and treatment of patients with diabetic nephropathy Kosachunhanun, N.
Leelawatana, R.
Prathipanawatr, T.
Plengvidhya, N.
Chetthakul, T.
Mongkolsomlit, S.
Rawdaree, P.
2006
53. Thailand Diabetes Registry Project: Prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus Chetthakul, T.
Plengvidhya, N.
Kosachunhanun, N.
Leelawatana, R.
Prathipanawatr, T.
Mongkolsomlit, S.
Rawdaree, P.
2006
54. Thailand Diabetes Registry Project: Prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus Chetthakul, T
Deerochanawong, C
Suwanwalaikorn, S
Kosachunhanun, N
Ngarmukos, C
Rawdaree, P
Krittiyawong, S
Leelawatana, R
Bunnag, P
Plengvidhya, N
Pratipanawatr, T
Benjasuratwong, Y
Mongkolsomlit, S
2006
55. Thailand Diabetes Registry Project: Prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes Bunnag, P
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Kosachunhanun, N
Benjasuratwong, Y
Krittiyawong, S
Leelawatana, R
Pratipanawatr, T
Ngarmukos, C
Chetthakul, T
Puavilai, G
Mongkolsomlit, S
Rawdaree, P
2006
56. Thailand Diabetes Registry Project: Prevalence of vascular complications in long-standing type 2 diabetes Leelawattana, R
Pratipanawatr, T
Bunnag, P
Kosachunhanun, N
Suwanwalaikorn, S
Krittiyawong, S
Chetthakul, T
Plengvidhya, N
Benjasuratwong, Y
Deerochanawong, C
Mongkolsomlit, S
Ngarmukos, C
Rawdaree, P
2006
57. Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes. Rawdaree, P.
Chetthakul, T.
Kosachunhanun, N.
Plengvidhaya, N.
Leelawatana, R.
Pratipanawatr, T.
2006
58. Thailand Diabetes Registry (TDR) project: Clinical status and long term vascular complications in diabetic patients Rawdaree, P.
Chetthakul, T.
Kosachunhanun, N.
Plengvidhya, N.
Leelawatana, R.
Prathipanawatr, T.
Mongkolsomlit, S.
2006
59. Abdominal epilepsy: an uncommon of nonconvulsive status epilepticus S. Tiamkao
T. Pratipanawatr
S. Jitpimolmard
2007
60. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia Reungjui, S
Pratipanawatr, T
Johnson, RJ
Nakagawa, T
2008
61. Prediction of seizure control in non-ketotic hyperglycemic induced seizures Tiamkao, S
Janon, C
Sawanyawisuth, K
Pratipanawatr, T
Jitpimolmard, S
2009
62. Efficacy and safety of generic and original pioglitazone in type 2 diabetes mellitus: A multicenter, a double-blinded, randomized-controlled study Rawdaree, P
Deerochanawong, C
Peerapatdit, T
Thongtang, N
Suwanwalaikorn, S
Khemkha, A
Benjasuratwong, Y
Boonyavarakul, A
Chetthakul, T
Leelawattana, R
Ngarmukos, C
Viwatwongkasem, C
Pratipanawatr, T
Kosachunhanun, N
2010
63. Thailand diabetic registry cohort: Predicting death in Thai diabetic patients and causes of death Pratipanawatr, T
Rawdaree, P
Chetthakul, T
Bunnag, P
Ngarmukos, C
Benjasuratwong, Y
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Krittiyawong, S
Mongkolsomlit, S
Komoltri, C
2010
64. Abdominal epilepsy: An uncommon of non-convulsive status epilepticus Tiamkao, S
Pratipanawatr, T
Jitpimolmard, S
2011
65. Modified Thai Diabetes Risk Score as a Screening Tool For Identification Metabolic Syndrome Siwakorn Porntrakulphiphat
Kaewjai Thepsuthammarat
Tatiya Treapkhuntong
Thongchai Pratipanawatr
2011
66. Factors influencing chronic diabetic complications in type 1 diabetes Panamonta, N.
Prathipanawatr, T.
Panamonta, O.
2012
67. Achievement in National Licensing Examination Steps I and II of Khon Kaen Medical Students from Various Programs Pranom Buppasiri
Piyathida Kuhiranratn
Chulapan Engchanil
Pungpayom Kaewpila
Sirinan Sila-on
Thongchai Pratipanawatr
2013
68. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus P. Gabriel Steg
Jaime Davidson
Elaine B. Hoffman
Nihar R. Desai
Darren K. McGuire
Lawrence A. Leiter
Itamar Raz
Eugene Braunwald
Deepak L. Bhatt
Benjamin M. Scirica
Jacob A. Udell
Matthew A. Cavender
Nihar Desai
Timothy Abrahamsen
Michelle Grossman
Suzanne Morin
Kyungah Im
Elaine Hoffman
Daniel Gabovitch
Alexandra Pricken
Ofri Mosenzon
Alona Buskila
Peter Ohman
Boaz Hirshberg
Christina Stahre
Deborah Price
Solveig Billing-Clason
Karin Sabel
John Monyak
Mikalea Sjostrand
Cheryl Wei
Jane Lu
Elinor Miller
Joel Raichlen
Sandy Fitt
Robert Frederich
Nayyar Iqbal
Mark Donovan
Jaime A. Davidson
Ph. Gabriel Steg
Carlos Aguilar-Salinas
Michael Alvarsson
John Amerena
Diego Ardissino
Oleg Averkov
Angelo Avogaro
Anthony Barnett
Reinhard Bretzel
Chern-En Chiang
Verner Codoceo
Ramon Corbalan
Anthony Dalby
Harald Darius
Chaicharn Deerochanawong
Mikael Dellborg
Freddy Eliaschewitz
Armando Garcia-Castillo
Ramon Gomis
Patrick Henry
Joost Hoekstra
Gyorgy Jermendy
John Kastelein
Anthony Keech
Robert Kiss
Michel Krempf
Markku Laakso
Lawrence Leiter
Eran Leitersdorf
Basil Lewis
Leon Litwak
Jose Lopez-Sendon
Ronald Ma
Darren McGuire
Felix Medina
Robert Moses
Jose C. Nicolau
Grzegorz Opolski
Ton Oude Ophuis
Ernesto Paolasso
Kausik K. Ray
Mikhail Ruda
K. M. Prasanna Kumar
Marina Shestakova
Wayne H-H Sheu
Alena Smahelova
B. Soma Raju Bhupathiraju
Jindrich Spinar
Piyamitr Sritata
Krysztof Strojeck
Jaime E. Villena-Chavez
Weiping Jia
Young Huo
Stephen D. Wiviott
Cheryl Lowe
Eric Awtry
Clifford Berger
Akshay S. Desai
Eli Gelfand
David Leeman
Mark Link
Frederick Ruberg
Joseph Vita
Natalia Rost
Scott Silverman
Norton J. Greenberger
Markus M. Lerch
Bernard Gersh
Richard Nesto
Stefano Del Prato
Jaakko Tuomilehto
Sheryl Kelsey
A. Alvarisqueta
J. Cuadrado
L. Rista
S. Hermida
C. Baccaro
C. Luquez
M. Lagrutta
L. Maffei
I. Bartolacci
O. Montana
H. Cutuli
M. Berli
A. Lorenzatti
G. Frechtel
R. La Greca
O. Fretes
M. Diaz
N. Rodriguez Papini
E. Farias
C. Issa
A. Elbert
R. Lehman
M. Arya
B. Singh
D. Colquhoun
R. Jayasinghe
F. de Looze
P. Blombery
G. Ward
G. Szto
W. Abhayaratna
J. Borges
L. Russo
J. Felicio
F. Santos
F. Guimaraes Filho
M. Lazaretti Castro
P. Rossi
D. Armaganijan
P. Leaes
F. Bandeira
M. Franken
N. Rassi
R. Rea
M. Zanella
C. Amodeo
L. Cesar
R. Betti
A. Chacra
H. Schmid
A. Bell
G. Syan
R. Zadra
H. Conter
R. Dumas
D. Borts
I. Dattani
P. Poirier
J. Cha
P. Dzongowski
R. Labonte
B. St Pierre
D. Gaudet
S. Kouz
A. Lamy
S. Tishler
R. Chehayeb
J. Bedard
I. Hramiak
I. Teitelbaum
C. Fortin
V. Woo
J. Conway
S. Robinson
B. Sussex
J. Chiasson
N. Muirhead
S. Bose
A. Ouellet
J. Yale
R. Bhargava
D. Lau
S. Tobe
P. Perron
J. Sigalas
L. Bilodeau
R. Tytus
G. Achyuthan
M. Pearce
A. Steele
G. Bailey
P. Ma
F. St-Maurice
D. Rupka
R. Houlden
A. Bailey
G. Rewa
P. Sohal
R. Ting
J. Prieto
M. Rodriguez
G. Godoy
G. Larenas
C. Pincetti
L. Cobos
V. Saavedra
P. Varleta
F. Lucero
O. Kuzmanic
M. Acevedo
M. Aguirre
F. Florenzano
J. Ma
Y. Bao
M. Jiang
W. Xu
Y. Shi
M. Zheng
Y. Li
Y. Dong
W. Zhao
M. Sun
M. Lei
J. Wang
Z. Pistek
I. Rihacek
D. Kucera
M. Brada
R. Naplava
J. Karasova
H. Vlasicova
J. Skopecek
L. Spinarova
L. Raclavska
R. Sarbochova
L. Okenka
E. Racicka
K. Urbancova
M. Oznerova
Z. Lorenc
B. Wasserburger
E. Zahumensky
H. Gruenfeldova
J. Hradec
M. Lukac
S. Svacina
J. Podzimek
L. Hemzsky
I. Mikulkova
J. Pavlickova
T. Brychta
J. Chochola
T. Couffinhal
M. Elbaz
C. Petit
B. Faller
R. Marechaud
P. Moulin
S. Fendri
P. Nazeyrollas
U. Wendisch
K. Busch
G. Klausmann
H. Duengen
K. Appel
N. Toursarkissian
T. Jung
P. Ott
I. Schenkenberger
D. Kuesters
B. Landers
R. Nischik
H. Fischer
D. Tschoepe
B. Paschen
K. Krause
K. Derwahl
V. Wenzl-Bauer
A. Hamann
H. Strotmann
K. Milek
S. Mueller
K. Tan
C. Tsang
D. Chu
B. Tomlinson
K. Kung
L. Koranyi
Z. Kerenyi
B. Benczur
L. Illyes
T. Hidvegi
A. Somogyi
J. Valco
S. Ferenczi
J. Rapi
P. Voeroes
G. Winkler
T. Sydo
M. Hetey
K. Simon
J. Penzes
P. Kempler
B. Bako
Z. Lengyel
I. Witmann
M. Dudas
G. Vandorfi
J. Takacs
A. Matoltsy
E. Ladanyi
A. Gyimesi
S. Sadikot
K. Parikh
S. Jain
C. Yajnik
A. Sosale
P. Shamanna
S. Srikanta
S. Shah
A. Srinivas
D. Banker
P. Shah
A. Sharda
B. Makkar
N. Desai
N. Rais
H. Mardikar
A. Mishra
S. Bhupati
J. Menon
S. Sathe
R. Gupta
V. Sharma
M. Darawsha
T. Herskovits
S. Hamoud
E. Nikolsky
F. Adawi
D. Tsalihin
J. Wainstein
E. Klainman
M. Mosseri
Y. Yerushalmi
E. Karnieli
H. Knobler
R. Zimlichman
S. Benchetrit
A. Tsur
Y. Yagil
S. Atar
I. Beberashvili
S. Fuchs
N. Stern
A. Pollak
T. Chajek-Shaul
Y. Rozenman
A. Biton
E. Bramucci
A. Fiscella
V. Grassia
P. Piatti
S. De Cosmo
L. Di Lorenzo
P. Merlini
E. Mannucci
S. Frontoni
R. Trevisan
L. Zenari
C. Lambiase
A. Salvioni
O. Silvestri
G. Ambrosio
P. Di Bartolo
L. Fattore
P. Presbitero
M. Calabrese
R. Evola
M. Alcocer Gamba
M. Odin de los Rios Ibarra
E. Cardona Munoz
D. Reyes Sanchez
C. Hernandez Herrera
J. Perez Rios
E. Bayram Llamas
G. Llamas Esperon
E. Garcia Cantu
J. Nunez Fragoso
J. Gonzalez Gonzalez
G. Rivera Martinez
F. Padilla Padilla
G. Melendez Mier
D. Herrera Marmolejo
J. Garza Ruiz
N. Caracas Portilla
E. Lopez Rosas
G. Mendez Machado
J. Chevaile Ramos
I. Rodriguez Briones
M. W. J. van Hessen
S. Strikwerda
S. H. K. The
A. Kooy
E. Ronner
P. R. Nierop
J. J. Remmen
B. E. Groenemeijer
B. J. B. Hamer
D. C. G. Basart
H. W. O. Roeters van Lennep
M. Nieuwdorp
M. P. M. van Dijk
S. Kentgens
W. W. van Kempen
J. Hoogendijk
W. Spiering
C. Voors-Pette
V. Kose
D. E. P. de Waard
F. Gonkel
H. A. H. Kaasjager
G. M. Rojas Lingan
I. Agous
H. J. Kruik
B. P. M. Imholz
M. Pieterse
H. Manrique
J. Villena
L. Leon
K. Kundert
J. Minchola
M. Pinto
J. Heredia
A. Rodriguez
C. Guerreros
P. Berrospi
C. Zubiate
A. Allemant
H. Arbanil
W. Ponciano
J. Calderon
R. Lisson
L. Segura
A. Sidorowicz-Bialynicka
R. Sciborski
I. Fares
P. Mader
J. Skierkowska
T. Stasinska
W. Pomiecko
M. Skorski
E. Krzyzagorska
M. Polaszewska-Muszynska
D. Sowinski
K. Strojek
J. Rosinska-Migda
P. Romanczuk
G. Golebiowski
J. Kubica
T. Mazurek
L. Wojnowski
D. Pasternak
P. Stachlewski
E. Trzepla
G. Bogdanowicz
A. Uzunow
I. Potakowska
Z. Miszczyszyn
T. Waszyrowski
O. Smolenskaya
Y. Lukyanov
N. Vorokhobina
Y. Khalimov
O. Orlikova
A. Rebrov
V. Kukharchuk
S. Boldueva
M. Arkhipov
T. Zhelninova
E. Pavlysh
M. Antsiferov
A. Panov
M. Pavlova
S. Shustov
E. Demchenko
A. Galyavich
E. Malakhina
O. Semenova
Z. Kobalava
S. Kotova
I. Gavrisheva
E. Oschepkova
Y. Karpov
B. Sidorenko
O. Kislyak
A. Ametov
A. Dreval
E. Grineva
A. Mkrtumyan
T. Tyurina
O. Sazonova
F. Bonnici
N. Ranjith
L. Burgess
H. Nortje
L. Distiller
I. Mitha
R. Moore
M. Conradie
A. Horak
S. Pillay
H. Wellmann
E. Berg
P. Pillai
T. Padayachee
C. Corbett
H. Makan
J. Wing
Z. Vawda
I. Ebrahim
A. Dalby
E. Mitha
A. Bhorat
J. Cruz Fernandez
C. Munoz
J. Bruguera Cortada
A. Castro Conde
C. Calvo
B. Gil Extremera
E. Delgado
L. Masmiquel
J. Garcia Puig
L. de Teresa Parreno
D. Mauricio
J. Redon
M. Brito
C. Lopez
J. Segura de la Morera
C. Linderfalk
H. Larnefeldt
A. Olsson
L. Lonneborg
M. Ekelund
B. Samad
B. Borgencrantz
J. Nilsson
O. Berglund
M. Svensson
T. Mooe
D. Curiac
J. Albin
E. Angesjo
O. Lannemyr
C. Chiang
W. Sheu
J. Chen
K. Tien
K. Ueng
W. Lai
W. Yin
Y. Hung
K. Shyu
J. Hou
H. Lam
P. Laothavorn
S. Kuanprasert
W. Khovidhunkit
Y. Benjasuratwong
C. Chotinaiwattarakul
S. Mamanasiri
S. Suraamornkul
T. Pratipanawatr
W. Nitiyanant
S. Heller
K. Ray
R. Pieters
C. Strang
B. Bodalia
A. Middleton
T. Hall
G. Chapman
J. Calvert
R. Reed
D. Tam
G. Butcher
N. Jones
A. Takhar
W. Turner
D. McNally
O. Corey
J. Chapman
S. Mohr
S. Edwards
D. Bhatt
J. Davidson
A. Ocampo
D. Kandath
Y. Aude
W. Ervin
V. Savin
R. Anderson
R. Littlefield
M. Oberoi
George E. Platt
S. Yazdani
R. Mangoo-Karim
J. Walder
H. Gogia
Y. Chandrashekhar
F. Boccalandro
W. Rogers
S. Bilazarian
F. Zieve
Y. Siage
T. O'Connor
S. Mudaliar
A. Nikas
R. Giusti
R. Glover
S. Chilka
W. French
E. Roth
N. Singh
R. Christofferson
M. Stich
S. Dagogo-Jack
J. Allison
G. Arroyo Zengotita
R. Ison
B. Iteld
M. Sulistio
E. Gonzalez
T. Gorman
E. Hage-Korban
R. Reddy
W. Byars
M. Antonishen
S. Benjamin
B. First
J. Rosado
H. Bruschetta
P. Mehta
T. Poling
C. Rosendorff
Howard J. Kerstein
F. Saba
J. Willis
K. Adams
E. Camilo Vazquez
H. Ellison
B. Kahn
D. Kereiakes
S. Powell
P. Raskin
K. Smith
S. Varma
F. Whittier
R. Casanova
S. Isserman
W. Kaye
W. McGuinn
A. Bartkowiak
L. Dworkin
Carlos A. Labrador
D. Podlecki
M. Popovtzer
S. Aronoff
C. Ballantyne
Elena Gonzalez-Ortiz
A. Mora
T. Pitts
S. Reinhardt
G. Soucie
W. Wainwright
B. Henson
N. Sklaver
R. Arakaki
J. Brown
G. Chalavarya
R. Chochinov
T. Dixon
M. Kutner
R. Perlman
A. Raisinghani
A. Salacata
V. Awasty
V. Elinoff
W. George
A. LaRochelle-Gryseels
A. Mercado
G. Miller
M. Qureshi
A. Steljes
F. Wefald
J. Wilson
J. Chinn
Rita B. Chuang
A. Comulada-Rivera
I. Hartman
P. Narayan
T. Pacheco
R. Weiss
J. Beavins
J. Creevy
G. Hamroff
R. Hodson
E. Kosinski
P. Krichmar
R. Patel
R. Schneider
J. Shapiro
D. Sharp
J. Speer
R. Stegemoller
F. Waxman
F. Young Chang
E. Braun
F. Eder
S. Minor
M. Albert
Kenneth W. Carr
B. Diaczok
I. Gastman
V. Gupta
K. Longshaw
J. M. Gonzalez-Campoy
M. Raikhel
J. Thomas
K. Wood
I. Diab
J. Furda
M. Gelernt
M. Halter
B. House
S. Kaster
G. Raad
R. Stamatin
B. Barker
R. Blonder
Robert J. Bloomberg
R. Burgos Calderon
A. Carrol
A. Comerota
M. Feinglos
D. Henderson
R. Kastelic
Larry D. Stonesifer
J. Talano
P. Ver Lee
J. Brosseau
W. Clark
E. Cohen
J. Fialkow
K. Horton
H. Kozman
J. McGill
C. Mihills
R. Poonawala
K. Shore
L. Tejada
R. Torres
W. Wright
G. Calatayud
H. Chandna
R. Drozdiak
R. Fink
R. Gill
M. Glandt
Daniel W. Gottlieb
T. Hack
J. Kay
V. Mansouri
T. McKnight
E. Mostel
L. Schmidt
H. Seide
E. Sonel
R. Taylor
M. Velasquez
E. Bretton
R. Feldman
A. Hartman
K. Hershon
Charles R. Leach
E. Martin
F. Mohiuddin
Y. Naygandhi
T. Riske
S. Schima
E. R. Uzoaga
H. Ward
R. Weinstock
T. Williams
A. Altschuller
T. Aoki
S. Blumenthal
A. Cash
Gilbert Eisner
J. Gutmann
M. Hagan
A. Kabour
T. Markus
W. McKenzie
M. Moursi
P. Mystkowski
F. Ovalle
R. Perkins
L. Popeil
R. Saniuk
Y. Sierra
O. Alvarado
J. Anderson
M. Bajaj
R. Blank
A. Chu
L. Levinsky
P. Levy
J. Osborne
H. Pavon
D. Sanderlin
G. Schaer
S. Zarich
K. Atassi
C. Bayron
M. Casagrande
D. Das
M. Gimness
F. Handel
T. Kinstrey
S. Leu
K. Osei
J. Soba Nouel
Z. Soltani
H. Sussman
K. Chiu
R. Duda
K. Farnsworth
M. Lano
F. Lee
P. Levin
S. Pratt
R. Richwine
L. Ruiz-Rivera
J. Turner
J. Wood
William D. Zigrang
Hernan R. Baquerizo
Carlos Benitez Colon
J. Demattia
V. Desai
D. Fitz-Patrick
S. Goral
A. Odhav
A. Prentiss
C. Ruff
W. Wu
K. Wyne
Lisa G. Abbott
R. Applegate
J. Cabral
P. Kotha
P. Ortega
D. Simmons
2013
69. Smoking and death in Thai diabetic patients: the Thailand Diabetic Registry cohort. Pratipanawatr, T.
Rawdaree, P.
Chetthakul, T.
Leelawatana, R.
Kosachunhanun, N.
Plengvidhya, N.
Mongkolsomlit, S.
2013
70. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. Nataporn Chaipichit
Janet Krska
Thongchai Pratipanawatr
Verawan Uchaipichat
Narumol Jarernsiripornkul
2014
71. Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2014
72. DIFFERENCES IN MORTALITY BY EDUCATION LEVEL AMONG PATIENTS IN DIABETIC REGISTRY FOR THAILAND Pratipanawatr, T.
Rawdaree, P.
Chetthakul, T.
Leelawatana, R.
Kosachunhanun, N.
Plengvidhya, N.
Mongkolsomlit, S.
2015
73. Experiences of adverse drug effects reported by patients in ambulatory clinic Narumol Jarernsiripornkul
Nataporn Chaipichit
Janet Krska
Verawan Uchaipichat
Thongchai Pratipanawatr
2015
74. Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2015
75. Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries. Nataporn Chaipichit
Janet Krska
Thongchai Pratipanawatr
Narumol Jarernsiripornkul
2015
76. Difference of Bone Mineral Density between Postmenopausal Women with and Without Metabolic Syndrome Siriruthai Amnatbuddee
Woraluck Somboonporn
Sukree Soontrapa
Srinaree Kaewrudee
Thongchai Pratipanawatr
2016
77. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions Jarernsiripornkul, N
Chaipichit, N
Pratipanawatr, T
Uchaipichat, V
Krska, J
2016
78. Attitude towards usefulness of patient information leaflets among ambulatory patients Supawinee Pongpunna
Thongchai Pratipanawatr
Narumol Jarernsiripornkul
2018
79. Confidence and accuracy in identification of adverse drug reactions reported by outpatients Sirinya Kampichit
Thongchai Pratipanawatr
Narumol Jarernsiripornkul
2018
80. Differences in mortality rate by anti-hyperglycemic regimens among patients in the Thailand diabetic registry project Pratipanawatr, T. 2018
81. Prevalence and associated clinical parameters of a hyperglycemic emergency among type 2 diabetic patients: A nationwide cross-sectional study in Thailand Pratipanawatr, T. 2018
82. Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand Pratipanawatr, T
Satirapoj, B
Ongphiphadhanakul, B
Suwanwalaikorn, S
Nitiyanant, W
2019
83. Survey of outpatients' use and needs of patient medicine information leaflets in Thailand Pratipanawatr, T.
Jarernsiripornkul, N.
2019
84. Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study). Young Min Cho
Chaicharn Deerochanawong
Samroeng Seekaew
Swangjit Suraamornkul
Sunun Benjachareonwong
Sarinya Sattanon
Parinya Chamnan
Thanitha Sirirak
Natapong Kosachunhanun
Thongchai Pratipanawatr
Sompongse Suwanwalaikorn
Woo Je Lee
Sungrae Kim
Seonghui Choi
Eun Seok Kang
Taekeun Oh
Sam Kwon
Moon-Kyu Lee
2020
85. Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): A multicentre, cross-sectional study in Thailand Satirapoj, B
Pratipanawatr, T
Ongphiphadhanakul, B
Suwanwalaikorn, S
Benjasuratwong, Y
Nitiyanant, W
2020
Count 54 47 53 5

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Group A beta-hemolytic streptococcal meningitis in adults. Chotmongkol, V.
Prathipanawatra, T.
Rojviroj, S.
1989 Journal of the Medical Association of Thailand
10 (72), pp. 545-547
2. Unusual manifestation in a case of nocardial meningitis. Chotmongkol, V.
Prathipanawatra, T.
Tiamkao, S.
1993 Journal of the Medical Association of Thailand
11 (76), pp. 638-640
3. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle Cusi, K.A.
Pendergrass, M.L.
Pratipanawatr, T.
2000 Journal of Clinical Investigation
3 (105), pp. 311-320
4. Regulation of MAP kinase pathway activity in vivo in human skeletal muscle Pendergrass, M.L.
Cusi, K.A.
Pratipanawatr, T.
2000 American Journal of Physiology - Endocrinology and Metabolism
6 41-6 (278), pp. E992-E999
5. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes Cusi, K.A.
Pratipanawatr, T.
2001 Metabolism: Clinical and Experimental
5 (50), pp. 602-606
6. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis Pratipanawatr, T.
Kumar, V.
Cusi, K.A.
2001 American Journal of Physiology - Endocrinology and Metabolism
5 43-5 (280), pp. E712-E719
7. Skeletal Muscle Insulin Resistance in Normoglycemic Subjects with a Strong Family History of Type 2 Diabetes is Associated with Decreased Insulin-Stimulated Insulin Receptor Substrate-1 Tyrosine Phosphorylation Pratipanawatr, T.
Cusi, K.A.
2001 Diabetes
7-12 (50), pp. 2572-2578
8. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects Pratipanawatr, T.
Cusi, K.A.
2002 American Journal of Physiology - Endocrinology and Metabolism
6 45-6 (282), pp. E1360-E1368
9. Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects Pratipanawatr, T. 2002 Diabetes, Obesity and Metabolism
3 (4), pp. 195-200
10. Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans Pratipanawatr, T.
Cusi, K.A.
2002 American Journal of Physiology - Endocrinology and Metabolism
2 46-2 (283), pp. E346-E352
11. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes Pratipanawatr, T.
Cusi, K.A.
2002 Diabetes
10 (51), pp. 3043-3048
12. Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes Pratipanawatr, T.
Cusi, K.A.
2002 Diabetes
2 (51), pp. 462-468
13. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes Pratipanawatr, T.
Cusi, K.A.
2003 Diabetes
10 (52), pp. 2461-2474
14. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action Pratipanawatr, T. 2003 Journal of Applied Physiology
6 (95), pp. 2519-2529
15. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes Pratipanawatr, T. 2003 Diabetes
6 (52), pp. 1364-1370
16. Seizures in nonketotic hyperglycaemia Tiamkao, S.
Pratipanawatr, T.
Tiamkao, S.
Nitinavakarn, B.
Chotmongkol, V.
Jitpimolmard, S.
2003 Seizure
6 (12), pp. 409-410
17. Ceramide Content Is Increased in Skeletal Muscle from Obese Insulin-Resistant Humans Pratipanawatr, T. 2004 Diabetes
1 (53), pp. 25-31
18. Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients Pratipanawatr, T. 2004 Journal of Clinical Endocrinology and Metabolism
1 (89), pp. 200-206
19. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects Pratipanawatr, T. 2004 Metabolism: Clinical and Experimental
9 (53), pp. 1233-1242
20. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients Pratipanawatr, T. 2004 International Journal of Obesity
6 (28), pp. 783-789
21. Dose-response effect of elevated plasma free fatty acid on insulin signaling Pratipanawatr, T.
Cusi, K.A.
2005 Diabetes
6 (54), pp. 1640-1648
22. Prevalence of dyslipidemia in rural Thai adults: An epidemiologic study in Khon Kaen province Pongchaiyakul, C.
Pongchaiyakul, C.
Pratipanawatr, T.
2005 Journal of the Medical Association of Thailand
8 (88), pp. 1092-1097
23. Increased collagen content in insulin-resistant skeletal muscle Pratipanawatr, T.
De Filippis, E.A.
2006 American Journal of Physiology - Endocrinology and Metabolism
3 (290), pp. E560-E565
24. Myasthenia gravis accompanied with hypokalemic periodic paralysis Sawanyawisuth, K.
Tiamkao, S.
Pratipanawatr, T.
2006 Journal of the Medical Association of Thailand
5 (89), pp. 727-729
25. Reduced skeletal muscle inhibitor of κBβ content is associated with insulin resistance in subjects with type 2 diabetes: Reversal by exercise training Sriwijitkamol, A.
Eagan, P.A.
Pratipanawatr, T.
2006 Diabetes
3 (55), pp. 760-767
26. Thailand Diabetes Registry Project: Current status of dyslipidemia in Thai diabetic patients Pratipanawatr, T.
Rawdaree, P.
Chetthakul, T.
Leelawatana, R.
Kosachunhanun, N.
Plengvidhya, N.
Mongkolsomlit, S.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S60-S65
27. Thailand Diabetes Registry Project: Glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage Kosachunhanun, N.
Mongkolsomlit, S.
Rawdaree, P.
Plengvidhya, N.
Leelawatana, R.
Pratipanawatr, T.
Chetthakul, T.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S66-S71
28. Thailand Diabetes Registry Project: Prevalence and risk factors associated with lower extremity amputation in Thai diabetics Rawdaree, P.
Leelawatana, R.
Kosachunhanun, N.
Plengvidhya, N.
Pratipanawatr, T.
Chetthakul, T.
Mongkolsomlit, S.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S43-S48
29. Thailand Diabetes Registry Project: Prevalence and risk factors of stroke in Thai diabetic patients Plengvidhya, N.
Leelawatana, R.
Pratipanawatr, T.
Kosachunhanun, N.
Chetthakul, T.
Mongkolsomlit, S.
Rawdaree, P.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S49-S53
30. Thailand Diabetes Registry Project: Prevalence, characteristics and treatment of patients with diabetic nephropathy Kosachunhanun, N.
Leelawatana, R.
Prathipanawatr, T.
Plengvidhya, N.
Chetthakul, T.
Mongkolsomlit, S.
Rawdaree, P.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S37-S42
31. Thailand Diabetes Registry Project: Prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus Chetthakul, T.
Plengvidhya, N.
Kosachunhanun, N.
Leelawatana, R.
Prathipanawatr, T.
Mongkolsomlit, S.
Rawdaree, P.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S17-S26
32. Thailand Diabetes Registry Project: Prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus Chetthakul, T.
Kosachunhanun, N.
Rawdaree, P.
Leelawatana, R.
Plengvidhya, N.
Pratipanawatr, T.
Mongkolsomlit, S.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S27-S36
33. Thailand Diabetes Registry Project: Prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes Plengvidhya, N.
Kosachunhanun, N.
Leelawatana, R.
Pratipanawatr, T.
Chetthakul, T.
Mongkolsomlit, S.
Rawdaree, P.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S72-S77
34. Thailand Diabetes Registry Project: Prevalence of vascular complications in long-standing type 2 diabetes Pratipanawatr, T.
Kosachunhanun, N.
Chetthakul, T.
Plengvidhya, N.
Mongkolsomlit, S.
Rawdaree, P.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S54-S59
35. Thailand Diabetes Registry Project: Type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes Rawdaree, P.
Chetthakul, T.
Kosachunhanun, N.
Plengvidhaya, N.
Leelawatana, R.
Pratipanawatr, T.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S10-S16
36. Thailand Diabetes Registry (TDR) project: Clinical status and long term vascular complications in diabetic patients Rawdaree, P.
Chetthakul, T.
Kosachunhanun, N.
Plengvidhya, N.
Leelawatana, R.
Prathipanawatr, T.
Mongkolsomlit, S.
2006 Journal of the Medical Association of Thailand
SUPPL. 1 (89), pp. S1-S9
37. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia Reungjui, S.
Pratipanawatr, T.
Johnson, R.J.
Nakagawa, T.
2008 Current Opinion in Nephrology and Hypertension
5 (17), pp. 470-476
38. Prediction of seizure control in non-ketotic hyperglycemic induced seizures Tiamkao, S.
Janon, C.
Sawanyawisuth, K.
Pratipanawatr, T.
Jitpimolmard, S.
2009 BMC Neurology
(9), pp.
39. Efficacy and safety of generic and original pioglitazone in type 2 diabetes mellitus: A multicenter, a double-blinded, randomized-controlled study Rawdaree, P.
Thongtang, N.
Khemkha, A.
Boonyavarakul, A.
Chetthakul, T.
Pratipanawatr, T.
Kosachunhanun, N.
2010 Journal of the Medical Association of Thailand
11 (93), pp. 1249-1255
40. Thailand diabetic registry cohort: Predicting death in Thai diabetic patients and causes of death Pratipanawatr, T.
Rawdaree, P.
Chetthakul, T.
Leelawatana, R.
Kosachunhanun, N.
Plengvidhya, N.
Mongkolsomlit, S.
2010 Journal of the Medical Association of Thailand
SUPPL 3 (93), pp. S12-S20
41. Abdominal epilepsy: An uncommon of non-convulsive status epilepticus Tiamkao, S.
Pratipanawatr, T.
Jitpimolmard, S.
2011 Journal of the Medical Association of Thailand
8 (94), pp. 998-1001
42. Factors influencing chronic diabetic complications in type 1 diabetes Panamonta, N.
Prathipanawatr, T.
Panamonta, O.
2012 Southeast Asian Journal of Tropical Medicine and Public Health
5 (43), pp. 1245-1251
43. Smoking and death in Thai diabetic patients: The Thailand diabetic registry cohort Pratipanawatr, T.
Rawdaree, P.
Chetthakul, T.
Leelawatana, R.
Kosachunhanun, N.
Plengvidhya, N.
Mongkolsomlit, S.
2013 Journal of the Medical Association of Thailand
3 (96), pp. 280-287
44. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions Chaipichit, N.
Krska, J.
Pratipanawatr, T.
Uchaipichat, V.
Jarernsiripornkul, N.
2014 European Journal of Clinical Pharmacology
5 (70), pp. 607-615
45. Differences in mortality by education level among patients in diabetic registry for thailand Pratipanawatr, T.
Rawdaree, P.
Chetthakul, T.
Leelawatana, R.
Kosachunhanun, N.
Plengvidhya, N.
Mongkolsomlit, S.
2015 Southeast Asian Journal of Tropical Medicine and Public Health
1 (46), pp. 125-132
46. Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries Chaipichit, N.
Krska, J.
Pratipanawatr, T.
Jarernsiripornkul, N.
2015 International Journal of Clinical Pharmacy
(), pp.
47. Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries Chaipichit, N.
Krska, J.
Pratipanawatr, T.
Jarernsiripornkul, N.
2015 International Journal of Clinical Pharmacy
2 (37), pp. 355-364
48. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions Jarernsiripornkul, N.
Chaipichit, N.
Pratipanawatr, T.
Uchaipichat, V.
Krska, J.
2016 Pharmacoepidemiology and Drug Safety
1 (25), pp. 54-63
49. Confidence and accuracy in identification of adverse drug reactions reported by outpatients Pratipanawatr, T.
Jarernsiripornkul, N.
2018 International Journal of Clinical Pharmacy
6 (40), pp. 1559-1567
50. Differences in mortality rate by anti-hyperglycemic regimens among patients in the Thailand diabetic registry project Pratipanawatr, T. 2018 Journal of the Medical Association of Thailand
5 (101), pp. S175-S184
51. Prevalence and associated clinical parameters of a hyperglycemic emergency among type 2 diabetic patients: A nationwide cross-sectional study in Thailand Pratipanawatr, T. 2018 Journal of the Medical Association of Thailand
7 (101), pp. S23-S29
52. Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand Pratipanawatr, T.
Satirapoj, B.
2019 Journal of Diabetes Research
(2019), pp.
53. Survey of outpatients’ use and needs of patient medicine information leaflets in Thailand Pratipanawatr, T.
Jarernsiripornkul, N.
2019 International Journal of Clinical Pharmacy
1 (41), pp. 141-150
54. Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study) Sirirak, T.
Kosachunhanun, N.
Pratipanawatr, T.
2020 Diabetes, Obesity and Metabolism
1 (22), pp. 123-127
55. Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): A multicentre, cross-sectional study in Thailand Satirapoj, B.
Pratipanawatr, T.
2020 BMJ Open
2 (10), pp.

Title Authors Year Journal title
1. Group A beta-hemolytic streptococcal meningitis in adults. Chotmongkol, V
Prathipanawatra, T
Rojviroj, S
1989 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
10 (72), pp. 545-7
2. Unusual manifestation in a case of nocardial meningitis. Chotmongkol, V
Prathipanawatra, T
Tiamkao, S
1993 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
11 (76), pp. 638-40
3. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. Cusi, K
Maezono, K
Osman, A
Pendergrass, M
Patti, ME
Pratipanawatr, T
DeFronzo, RA
Kahn, CR
Mandarino, LJ
2000 The Journal of clinical investigation
3 (105), pp. 311-20
4. Regulation of MAP kinase pathway activity in vivo in human skeletal muscle. Osman, AA
Pendergrass, M
Koval, J
Maezono, K
Cusi, K
Pratipanawatr, T
Mandarino, LJ
2000 American journal of physiology. Endocrinology and metabolism
6 (278), pp. E992-9
5. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis. Iozzo, P
Pratipanawatr, T
Pijl, H
Vogt, C
Kumar, V
Pipek, R
Matsuda, M
Mandarino, LJ
Cusi, KJ
DeFronzo, RA
2001 American journal of physiology. Endocrinology and metabolism
5 (280), pp. E712-9
6. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. Pratipanawatr, W
Pratipanawatr, T
Cusi, K
Berria, R
Adams, JM
Jenkinson, CP
Maezono, K
DeFronzo, RA
Mandarino, LJ
2001 Diabetes
11 (50), pp. 2572-8
7. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes. Cusi, KJ
Pratipanawatr, T
Koval, J
Printz, R
Ardehali, H
Granner, DK
Defronzo, RA
Mandarino, LJ
2001 Metabolism: clinical and experimental
5 (50), pp. 602-6
8. Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects. Lee, NA
Matsuda, M
Bressler, P
Pratipanawatr, T
Glass, L
Mandarino, LJ
DeFronzo, RA
2002 Diabetes, obesity & metabolism
3 (4), pp. 195-200
9. Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes. Pratipanawatr, T
Cusi, K
Ngo, P
Pratipanawatr, W
Mandarino, LJ
DeFronzo, RA
2002 Diabetes
2 (51), pp. 462-8
10. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects. Pratipanawatr, T
Pratipanawatr, W
Rosen, C
Berria, R
Bajaj, M
Cusi, K
Mandarino, L
Kashyap, S
Belfort, R
DeFronzo, RA
2002 American journal of physiology. Endocrinology and metabolism
6 (282), pp. E1360-8
11. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes. Bajaj, M
Pratipanawatr, T
Berria, R
Pratipanawatr, W
Kashyap, S
Cusi, K
Mandarino, L
DeFronzo, RA
2002 Diabetes
10 (51), pp. 3043-8
12. Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans. Bajaj, M
Berria, R
Pratipanawatr, T
Kashyap, S
Pratipanawatr, W
Belfort, R
Cusi, K
Mandarino, L
DeFronzo, RA
2002 American journal of physiology. Endocrinology and metabolism
2 (283), pp. E346-52
13. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Bajaj, M
Suraamornkul, S
Pratipanawatr, T
Hardies, LJ
Pratipanawatr, W
Glass, L
Cersosimo, E
Miyazaki, Y
DeFronzo, RA
2003 Diabetes
6 (52), pp. 1364-70
14. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Kashyap, S
Belfort, R
Gastaldelli, A
Pratipanawatr, T
Berria, R
Pratipanawatr, W
Bajaj, M
Mandarino, L
DeFronzo, R
Cusi, K
2003 Diabetes
10 (52), pp. 2461-74
15. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action. Christ-Roberts, CY
Pratipanawatr, T
Pratipanawatr, W
Berria, R
Belfort, R
Mandarino, LJ
2003 Journal of applied physiology (Bethesda, Md. : 1985)
6 (95), pp. 2519-29
16. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Bajaj, M
Suraamornkul, S
Hardies, LJ
Pratipanawatr, T
DeFronzo, RA
2004 International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity
6 (28), pp. 783-9
17. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Christ-Roberts, CY
Pratipanawatr, T
Pratipanawatr, W
Berria, R
Belfort, R
Kashyap, S
Mandarino, LJ
2004 Metabolism: clinical and experimental
9 (53), pp. 1233-42
18. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Adams, JM
Pratipanawatr, T
Berria, R
Wang, E
DeFronzo, RA
Sullards, MC
Mandarino, LJ
2004 Diabetes
1 (53), pp. 25-31
19. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. Bajaj, M
Suraamornkul, S
Piper, P
Hardies, LJ
Glass, L
Cersosimo, E
Pratipanawatr, T
Miyazaki, Y
DeFronzo, RA
2004 The Journal of clinical endocrinology and metabolism
1 (89), pp. 200-6
20. Prevalence of dyslipidemia in rural Thai adults: an epidemiologic study in Khon Kaen province. Pongchaiyakul, C
Pongchaiyakul, C
Pratipanawatr, T
2005 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
8 (88), pp. 1092-7
21. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Belfort, R
Mandarino, L
Kashyap, S
Wirfel, K
Pratipanawatr, T
Berria, R
Defronzo, RA
Cusi, K
2005 Diabetes
6 (54), pp. 1640-8
22. Thailand diabetes registry project: prevalence of vascular complications in long-standing type 2 diabetes. Leelawattana, R
Pratipanawatr, T
Bunnag, P
Kosachunhanun, N
Suwanwalaikorn, S
Krittiyawong, S
Chetthakul, T
Plengvidhya, N
Benjasuratwong, Y
Deerochanawong, C
Mongkolsomlit, S
Ngarmukos, C
Rawdaree, P
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S54-9
23. Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients. Pratipanawatr, T
Rawdaree, P
Chetthakul, T
Bunnag, P
Ngarmukos, C
Benjasuratwong, Y
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Krittiyawong, S
Mongkolsomlit, S
Komoltri, C
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S60-5
24. Myasthenia gravis accompanied with hypokalemic periodic paralysis. Sawanyawisuth, K
Tiamkao, S
Pratipanawatr, T
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
5 (89), pp. 727-9
25. Thailand diabetes registry project: prevalence and risk factors of stroke in thai diabetic patients. Plengvidhya, N
Leelawatana, R
Pratipanawatr, T
Deerochanawong, C
Krittiyawong, S
Bunnag, P
Kosachunhanun, N
Suwanwalaikorn, S
Benjasuratwong, Y
Chetthakul, T
Ngarmukos, C
Vannasaeng, S
Mongkolsomlit, S
Komoltri, C
Rawdaree, P
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S49-53
26. Thailand diabetes registry project: prevalence and risk factors associated with lower extremity amputation in Thai diabetics. Krittiyawong, S
Ngarmukos, C
Benjasuratwong, Y
Rawdaree, P
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Pratipanawatr, T
Chetthakul, T
Mongkolsomlit, S
Bunnag, P
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S43-8
27. Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Sriwijitkamol, A
Christ-Roberts, C
Berria, R
Eagan, P
Pratipanawatr, T
DeFronzo, RA
Mandarino, LJ
Musi, N
2006 Diabetes
3 (55), pp. 760-7
28. Increased collagen content in insulin-resistant skeletal muscle. Berria, R
Wang, L
Richardson, DK
Finlayson, J
Belfort, R
Pratipanawatr, T
De Filippis, EA
Kashyap, S
Mandarino, LJ
2006 American journal of physiology. Endocrinology and metabolism
3 (290), pp. E560-5
29. Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes. Bunnag, P
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Kosachunhanun, N
Benjasuratwong, Y
Krittiyawong, S
Leelawatana, R
Pratipanawatr, T
Ngarmukos, C
Chetthakul, T
Puavilai, G
Mongkolsomlit, S
Rawdaree, P
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S72-7
30. Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage. Kosachunhanun, N
Benjasuratwong, Y
Mongkolsomlit, S
Rawdaree, P
Plengvidhya, N
Leelawatana, R
Bunnag, P
Pratipanawatr, T
Krittiyawong, S
Suwanwalaikorn, S
Deerochanawong, C
Chetthakul, T
Ngarmukos, C
Komoltri, C
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S66-71
31. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus. Chetthakul, T
Deerochanawong, C
Suwanwalaikorn, S
Kosachunhanun, N
Ngarmukos, C
Rawdaree, P
Krittiyawong, S
Leelawatana, R
Bunnag, P
Plengvidhya, N
Pratipanawatr, T
Benjasuratwong, Y
Mongkolsomlit, S
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S27-36
32. Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes. Likitmaskul, S
Wacharasindhu, S
Rawdaree, P
Ngarmukos, C
Deerochanawong, C
Suwanwalaikorn, S
Chetthakul, T
Bunnag, P
Kosachunhanun, N
Plengvidhaya, N
Leelawatana, R
Krittiyawong, S
Benjasuratwong, Y
Pratipanawatr, T
2006 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(89), pp. S10-6
33. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Reungjui, S
Pratipanawatr, T
Johnson, RJ
Nakagawa, T
2008 Current opinion in nephrology and hypertension
5 (17), pp. 470-6
34. Prediction of seizure control in non-ketotic hyperglycemic induced seizures. Tiamkao, S
Janon, C
Sawanyawisuth, K
Pratipanawatr, T
Jitpimolmard, S
2009 BMC neurology
(9), pp. 61
35. Efficacy and safety of generic and original pioglitazone in type 2 diabetes mellitus: a multicenter, a double-blinded, randomized-controlled study. Rawdaree, P
Deerochanawong, C
Peerapatdit, T
Thongtang, N
Suwanwalaikorn, S
Khemkha, A
Benjasuratwong, Y
Boonyavarakul, A
Chetthakul, T
Leelawattana, R
Ngarmukos, C
Viwatwongkasem, C
Pratipanawatr, T
Kosachunhanun, N
2010 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
11 (93), pp. 1249-55
36. Thailand Diabetic Registry cohort: predicting death in Thai diabetic patients and causes of death. Pratipanawatr, T
Rawdaree, P
Chetthakul, T
Bunnag, P
Ngarmukos, C
Benjasuratwong, Y
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Krittiyawong, S
Mongkolsomlit, S
Komoltri, C
2010 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(93), pp. S12-20
37. Abdominal epilepsy: an uncommon of non-convulsive status epilepticus. Tiamkao, S
Pratipanawatr, T
Jitpimolmard, S
2011 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
8 (94), pp. 998-1001
38. Smoking and death in Thai diabetic patients: the Thailand Diabetic Registry cohort. Pratipanawatr, T
Rawdaree, P
Chetthakul, T
Bunnag, P
Ngarmukos, C
Benjasuratwong, Y
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Krittiyawong, S
Mongkolsomlit, S
Komoltri, C
,
2013 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
3 (96), pp. 280-7
39. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. Chaipichit, N
Krska, J
Pratipanawatr, T
Uchaipichat, V
Jarernsiripornkul, N
2014 European journal of clinical pharmacology
5 (70), pp. 607-15
40. Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries. Chaipichit, N
Krska, J
Pratipanawatr, T
Jarernsiripornkul, N
2015 International journal of clinical pharmacy
2 (37), pp. 355-64
41. DIFFERENCES IN MORTALITY BY EDUCATION LEVEL AMONG PATIENTS IN DIABETIC REGISTRY FOR THAILAND. Pratipanawatr, T
Rawdaree, P
Chetthakul, T
Bunnag, P
Ngarmukos, C
Benjasuratwong, Y
Leelawatana, R
Kosachunhanun, N
Plengvidhya, N
Deerochanawong, C
Suwanwalaikorn, S
Krittiyawong, S
Mongkolsomlit, S
Komoltri, C
2015 The Southeast Asian journal of tropical medicine and public health
1 (46), pp. 125-32
42. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. Jarernsiripornkul, N
Chaipichit, N
Pratipanawatr, T
Uchaipichat, V
Krska, J
2016 Pharmacoepidemiology and drug safety
1 (25), pp. 54-63
43. Confidence and accuracy in identification of adverse drug reactions reported by outpatients. Kampichit, S
Pratipanawatr, T
Jarernsiripornkul, N
2018 International journal of clinical pharmacy
6 (40), pp. 1559-1567
44. Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand. Pratipanawatr, T
Satirapoj, B
Ongphiphadhanakul, B
Suwanwalaikorn, S
Nitiyanant, W
2019 Journal of diabetes research
(2019), pp. 5903820
45. Survey of outpatients' use and needs of patient medicine information leaflets in Thailand. Pongpunna, S
Pratipanawatr, T
Jarernsiripornkul, N
2019 International journal of clinical pharmacy
1 (41), pp. 141-150
46. Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand. Satirapoj, B
Pratipanawatr, T
Ongphiphadhanakul, B
Suwanwalaikorn, S
Benjasuratwong, Y
Nitiyanant, W
2020 BMJ open
2 (10), pp. e031612
47. Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study). Cho, YM
Deerochanawong, C
Seekaew, S
Suraamornkul, S
Benjachareonwong, S
Sattanon, S
Chamnan, P
Sirirak, T
Kosachunhanun, N
Pratipanawatr, T
Suwanwalaikorn, S
Lee, WJ
Kim, S
Choi, S
Kang, ES
Oh, T
Kwon, S
Lee, MK
2020 Diabetes, obesity & metabolism
1 (22), pp. 123-127

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Effect of a chronic elevation in plasma free fatty acids on insulin secretion and action in non-diabetic offspring with a strong family history of T2DM S Kashyap
R Belfort
T Pratipanawatr
R Berria
W Pratipanawatr
M Bajaj
L Mandarino
R Defronzo
K Cusi
2001 DIABETES
(50.0), pp. A81-A82
2 0 0 0 0 0 2
2. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes KJ Cusi
T Pratipanawatr
J Koval
R Printz
H Ardehali
DK Granner
RA DeFronzo
LJ Mandarino
2001 METABOLISM-CLINICAL AND EXPERIMENTAL
5.0 (50.0), pp. 602.0-606.0
19 0 0 0 0 0 19
3. Insulin-like growth factor-I (IGF-I) exerts less of an effect of FFA metabolism than insulin (INS) T Pratipanawatr
W Pratipanawatr
R Berria
M Bajaj
K Cusi
S Kashyap
R Aguiar
R Defronzo
2001 DIABETES
(50.0), pp. A304-A304
0 0 0 0 0 0 0
4. Insulin-stimulated insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation is decreased in normal glucose tolerant subjects with a strong family history of type 2 diabetes mellitus W Pratipanawatr
T Pratipanawatr
K Cusi
R Berria
J Adams
CY Christ
CP Jenkinson
RA Defronzo
LJ Mandarino
2001 DIABETES
(50.0), pp. A315-A315
0 0 0 0 0 0 0
5. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis P Iozzo
T Pratipanawatr
H Pijl
C Vogt
V Kumar
R Pipek
M Matsuda
LJ Mandarino
KJ Cusi
RA DeFronzo
2001 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
5.0 (280.0), pp. E712-E719
57 0 0 0 0 0 57
6. Relationship between insulin stimulation of insulin receptor tyrosine phosphorylation and glucose disposal in human skeletal muscle C Jenkinson
K Maezono
LJ Mandarino
T Pratipanawatr
K Cusi
ML Pendergrass
J Koval
RA Defronzo
2001 DIABETES
(50.0), pp. A61-A62
0 0 0 0 0 0 0
7. Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation W Pratipanawatr
T Pratipanawatr
K Cusi
R Berria
JM Adams
CP Jenkinson
K Maezono
RA DeFronzo
LJ Mandarino
2001 DIABETES
11.0 (50.0), pp. 2572.0-2578.0
133 0 0 0 0 0 133
8. Splanchnic glucose uptake (SGU) in type 2 diabetes M Bajaj
R Berria
T Pratipanawatr
S Kashyap
W Pratipanawatr
L Mandarino
K Cusi
RA Defronzo
2001 DIABETES
(50.0), pp. A315-A315
0 0 0 0 0 0 0
9. Chronic elevation in plasma free fatty acids impairs insulin secretion in non-diabetic offspring with a strong family history of T2DM S Kashyap
R Belfort
T Pratipanawatr
R Berria
W Pratipanawatr
M Bajaj
L Mandarino
R Defronzo
K Cusi
2002 DIABETES
(51.0), pp. A12-A13
8 0 0 0 0 0 8
10. Chronic physiologic hyperinsulinemia reduces insulin action in skeletal muscle by impairing glucose phosphorylation K Cusi
G Nucci
T Pratipanawatr
R Pipek
C Cobelli
R Defronzo
2002 DIABETES
(51.0), pp. A567-A568
2 0 0 0 0 0 2
11. Decreased Akt expression in muscle from patients with type 2 diabetes mellitus is improved by exercise training CY Christ
T Pratipanawatr
R Belfort
S Kashyap
LJ Mandarino
2002 DIABETES
(51.0), pp. A60-A60
0 0 0 0 0 0 0
12. Dose-response effects of an acute elevation in plasma free fatty acids on insulin sensitivity in healthy subjects R Belfort
S Kashyap
K Wirfel
T Pratipanawatr
R Berria
W Pratipanawatr
L Mandarino
R Defronzo
K Cusi
2002 DIABETES
(51.0), pp. A334-A334
2 0 0 0 0 0 2
13. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects T Pratipanawatr
W Pratipanawatr
C Rosen
R Berria
M Bajaj
K Cusi
L Mandarino
S Kashyap
R Belfort
RA DeFronzo
2002 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
6.0 (282.0), pp. E1360-E1368
51 0 0 0 0 0 51
14. Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects NA Lee
M Matsuda
P Bressler
T Pratipanawatr
L Glass
LJ Mandarino
RA DeFronzo
2002 DIABETES OBESITY & METABOLISM
3.0 (4.0), pp. 195.0-200.0
3 0 0 0 0 0 3
15. Effect of pioglitazone on splanchnic glucose uptake, endogenous glucose production, and hepatic fat content in type 2 diabetes mellitus (T2DM) M Bajaj
S Suraamornkul
T Pratipanawatr
LJ Hardies
L Glass
Y Miyazaki
W Pratipanawatr
E Cersosimo
R Defronzo
2002 DIABETES
(51.0), pp. A35-A35
2 0 0 0 0 0 2
16. Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans M Bajaj
R Berria
T Pratipanawatr
S Kashyap
W Pratipanawatr
R Belfort
K Cusi
L Mandarino
RA DeFronzo
2002 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
2.0 (283.0), pp. E346-E352
30 0 0 0 0 0 30
17. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes M Bajaj
T Pratipanawatr
R Berria
W Pratipanawatr
S Kashyap
K Cusi
L Mandarino
RA DeFronzo
2002 DIABETES
10.0 (51.0), pp. 3043.0-3048.0
39 0 0 0 0 0 39
18. Free fatty acids reduce splanchnic glucose uptake in patients, with type 2 diabetes mellitus M Bajaj
T Pratipanawatr
S Suraamornkul
R Berria
W Pratipanawatr
S Kashyap
R Belfort
K Cusi
L Mandarino
RA Defronzo
2002 DIABETES
(51.0), pp. A334-A334
2 0 0 0 0 0 2
19. Intensive insulin therapy does not improve early insulin signaling defects in patients with type 2 diabetes K Cusi
T Pratipanawatr
W Pratipanawatr
J Finlayson
P Ngo
R Defronzo
L Mandarino
2002 DIABETES
(51.0), pp. A137-A137
0 0 0 0 0 0 0
20. Kinetics of Akt activation by insulin in human skeletal muscle JM Adams
T Pratipanawatr
LJ Mandarino
2002 DIABETES
(51.0), pp. A571-A571
0 0 0 0 0 0 0
21. Muscle contraction increases insulin-dependent Akt serine phosphorylation CY Christ
R Berria
T Pratipanawatr
R Belfort
S Kashyap
RA Defronzo
LJ Mandarino
2002 DIABETES
(51.0), pp. A252-A252
0 0 0 0 0 0 0
22. Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes T Pratipanawatr
K Cusi
P Ngo
W Pratipanawatr
LJ Mandarino
RA DeFronzo
2002 DIABETES
2.0 (51.0), pp. 462.0-468.0
52 0 0 0 0 0 52
23. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes S Kashyap
R Belfort
A Gastaldelli
T Pratipanawatr
R Berria
W Pratipanawatr
M Bajaj
L Mandarino
R DeFronzo
K Cusi
2003 DIABETES
10.0 (52.0), pp. 2461.0-2474.0
540 0 0 0 0 0 540
24. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action CY Christ-Roberts
T Pratipanawatr
W Pratipanawatr
R Berria
R Belfort
LJ Mandarino
2003 JOURNAL OF APPLIED PHYSIOLOGY
6.0 (95.0), pp. 2519.0-2529.0
60 0 0 0 0 0 60
25. Intramyocellular lipid (IMCL) is not associtated with insulin resistance in Asian (Thai) type 2 diabetic subjects T Pratipanawatr
E Mairiang
R Chotmongkol
2003 DIABETES
(52.0), pp. A294-A294
0 0 0 0 0 0 0
26. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes M Bajaj
S Suraamornkul
T Pratipanawatr
LJ Hardies
W Pratipanawatr
L Glass
E Cersosimo
Y Miyazaki
RA DeFronzo
2003 DIABETES
6.0 (52.0), pp. 1364.0-1370.0
368 0 0 0 0 0 368
27. Seizures in nonketotic hyperglycaemia T Pratipanawatr
S Tiamkao
B Nitinavakarn
V Chotmongkol
S Jitpimolmard
2003 SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
6.0 (12.0), pp. 409.0-410.0
43 0 0 0 0 0 43
28. The synergistic effect of exercise on insulin stimulation of glucose disposal (Rd) is accompanied by a synergistic increase in IRS-1 associated PI 3-kinase (PI3K) activity C Christ-Roberts
T Pratipanawatr
W Pratipanawatr
R Berria
R Belfort
L Mandarino
2003 DIABETES
(52.0), pp. A238-A238
0 0 0 0 0 0 0
29. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans JM Adams
T Pratipanawatr
R Berria
E Wang
RA DeFronzo
MC Sullards
LJ Mandarino
2004 DIABETES
1.0 (53.0), pp. 25.0-31.0
663 0 0 0 0 0 663
30. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients M Bajaj
S Suraamornkul
P Piper
LJ Hardies
L Glass
E Cersosimo
T Pratipanawatr
Y Miyazaki
RA Defronzo
2004 JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
1.0 (89.0), pp. 200.0-206.0
506 0 0 0 0 0 506
31. Effect of rosiglitazone on insulin sensitivity, liver fat content C-reactive protein and plasma adiponectin in patients with Thai type 2 diabetic subjects T Pratipanawatr
E Mailaing
W Pratipanawat
2004 DIABETES
(53.0), pp. A556-A556
0 0 0 0 0 0 0
32. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects CY Christ-Roberts
T Pratipanawatr
W Pratipanawatr
R Berria
R Belfort
S Kashyap
LJ Mandarino
2004 METABOLISM-CLINICAL AND EXPERIMENTAL
9.0 (53.0), pp. 1233.0-1242.0
179 0 0 0 0 0 179
33. Plasma C-reactive protein lowering effect of rosiglitazone associated with improving glycemic control T Pratipanawatr
R Chotmongkol
S Kanhasura
W Pratipanawatr
2004 DIABETOLOGIA
(47.0), pp. A255-A255
0 0 0 0 0 0 0
34. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients M Bajaj
S Suraamornkul
LJ Hardies
T Pratipanawatr
RA DeFronzo
2004 INTERNATIONAL JOURNAL OF OBESITY
6.0 (28.0), pp. 783.0-789.0
226 0 0 0 0 0 226
35. Dose-response effect of elevated plasma free fatty acid on insulin signaling R Belfort
L Mandarino
S Kashyap
K Wirfel
T Pratipanawatr
R Berria
RA DeFronzo
K Cusi
2005 DIABETES
6.0 (54.0), pp. 1640.0-1648.0
340 0 0 0 0 0 340
36. Excessive activation of the IkB/NFkB inflammatory pathway in skeletal muscle from subjects with type 2 diabetes mellitus (T2DM) A Sriwijitkamol
CY Christ-Roberts
R Berria
T Pratipanawatr
RA Defronzo
LJ Mandarino
N Musi
2005 DIABETES
(54.0), pp. A264-A265
0 0 0 0 0 0 0
37. IDF metabolic syndrome definition and Thai obesity subjects Thongchai Pratipanawatr
Nopawan Kittivat
2006 DIABETES
(55.0), pp. A398-A398
0 0 0 0 0 0 0
38. Increased collagen content in insulin-resistant skeletal muscle R Berria
LS Wang
DK Richardson
J Finlayson
R Belfort
T Pratipanawatr
EA De Filippis
S Kashyap
LJ Mandarino
2006 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
3.0 (290.0), pp. E560-E565
101 0 0 0 0 0 101
39. Reduced skeletal muscle inhibitor of kappa B beta content is associated with insulin resistance in subjects with type 2 diabetes: Reversal by exercise training - Reversal by exercise training A Sriwijitkamol
C Christ-Roberts
R Berria
P Eagan
T Pratipanawatr
RA DeFronzo
LJ Mandarino
N Musi
2006 DIABETES
3.0 (55.0), pp. 760.0-767.0
155 0 0 0 0 0 155
40. Abdominal epilepsy: an uncommon of nonconvulsive status epilepticus S. Tiamkao
T. Pratipanawatr
S. Jitpimolmard
2007 EPILEPSIA
(48.0), pp. 108.0-108.0
0 0 0 0 0 0 0
41. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia Sirirat Reungjui
Thongchai Pratipanawatr
Richard J. Johnson
Takahiko Nakagawa
2008 CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
5.0 (17.0), pp. 470.0-476.0
55 0 0 0 0 0 55
42. Prediction of seizure control in non-ketotic hyperglycemic induced seizures Somsak Tiamkao
Chitranon Janon
Kittisak Sawanyawisuth
Thongchai Pratipanawatr
Suthipun Jitpimolmard
2009 BMC NEUROLOGY
(9.0), pp.
7 0 0 0 0 0 7
43. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus P. Gabriel Steg
Jaime Davidson
Elaine B. Hoffman
Nihar R. Desai
Darren K. McGuire
Lawrence A. Leiter
Itamar Raz
Eugene Braunwald
Deepak L. Bhatt
Benjamin M. Scirica
Jacob A. Udell
Matthew A. Cavender
Nihar Desai
Timothy Abrahamsen
Michelle Grossman
Suzanne Morin
Kyungah Im
Elaine Hoffman
Daniel Gabovitch
Alexandra Pricken
Ofri Mosenzon
Alona Buskila
Peter Ohman
Boaz Hirshberg
Christina Stahre
Deborah Price
Solveig Billing-Clason
Karin Sabel
John Monyak
Mikalea Sjostrand
Cheryl Wei
Jane Lu
Elinor Miller
Joel Raichlen
Sandy Fitt
Robert Frederich
Nayyar Iqbal
Mark Donovan
Jaime A. Davidson
Ph. Gabriel Steg
Carlos Aguilar-Salinas
Michael Alvarsson
John Amerena
Diego Ardissino
Oleg Averkov
Angelo Avogaro
Anthony Barnett
Reinhard Bretzel
Chern-En Chiang
Verner Codoceo
Ramon Corbalan
Anthony Dalby
Harald Darius
Chaicharn Deerochanawong
Mikael Dellborg
Freddy Eliaschewitz
Armando Garcia-Castillo
Ramon Gomis
Patrick Henry
Joost Hoekstra
Gyorgy Jermendy
John Kastelein
Anthony Keech
Robert Kiss
Michel Krempf
Markku Laakso
Lawrence Leiter
Eran Leitersdorf
Basil Lewis
Leon Litwak
Jose Lopez-Sendon
Ronald Ma
Darren McGuire
Felix Medina
Robert Moses
Jose C. Nicolau
Grzegorz Opolski
Ton Oude Ophuis
Ernesto Paolasso
Kausik K. Ray
Mikhail Ruda
K. M. Prasanna Kumar
Marina Shestakova
Wayne H-H Sheu
Alena Smahelova
B. Soma Raju Bhupathiraju
Jindrich Spinar
Piyamitr Sritata
Krysztof Strojeck
Jaime E. Villena-Chavez
Weiping Jia
Young Huo
Stephen D. Wiviott
Cheryl Lowe
Eric Awtry
Clifford Berger
Akshay S. Desai
Eli Gelfand
David Leeman
Mark Link
Frederick Ruberg
Joseph Vita
Natalia Rost
Scott Silverman
Norton J. Greenberger
Markus M. Lerch
Bernard Gersh
Richard Nesto
Stefano Del Prato
Jaakko Tuomilehto
Sheryl Kelsey
A. Alvarisqueta
J. Cuadrado
L. Rista
S. Hermida
C. Baccaro
C. Luquez
M. Lagrutta
L. Maffei
I. Bartolacci
O. Montana
H. Cutuli
M. Berli
A. Lorenzatti
G. Frechtel
R. La Greca
O. Fretes
M. Diaz
N. Rodriguez Papini
E. Farias
C. Issa
A. Elbert
R. Lehman
M. Arya
B. Singh
D. Colquhoun
R. Jayasinghe
F. de Looze
P. Blombery
G. Ward
G. Szto
W. Abhayaratna
J. Borges
L. Russo
J. Felicio
F. Santos
F. Guimaraes Filho
M. Lazaretti Castro
P. Rossi
D. Armaganijan
P. Leaes
F. Bandeira
M. Franken
N. Rassi
R. Rea
M. Zanella
C. Amodeo
L. Cesar
R. Betti
A. Chacra
H. Schmid
A. Bell
G. Syan
R. Zadra
H. Conter
R. Dumas
D. Borts
I. Dattani
P. Poirier
J. Cha
P. Dzongowski
R. Labonte
B. St Pierre
D. Gaudet
S. Kouz
A. Lamy
S. Tishler
R. Chehayeb
J. Bedard
I. Hramiak
I. Teitelbaum
C. Fortin
V. Woo
J. Conway
S. Robinson
B. Sussex
J. Chiasson
N. Muirhead
S. Bose
A. Ouellet
J. Yale
R. Bhargava
D. Lau
S. Tobe
P. Perron
J. Sigalas
L. Bilodeau
R. Tytus
G. Achyuthan
M. Pearce
A. Steele
G. Bailey
P. Ma
F. St-Maurice
D. Rupka
R. Houlden
A. Bailey
G. Rewa
P. Sohal
R. Ting
J. Prieto
M. Rodriguez
G. Godoy
G. Larenas
C. Pincetti
L. Cobos
V. Saavedra
P. Varleta
F. Lucero
O. Kuzmanic
M. Acevedo
M. Aguirre
F. Florenzano
J. Ma
Y. Bao
M. Jiang
W. Xu
Y. Shi
M. Zheng
Y. Li
Y. Dong
W. Zhao
M. Sun
M. Lei
J. Wang
Z. Pistek
I. Rihacek
D. Kucera
M. Brada
R. Naplava
J. Karasova
H. Vlasicova
J. Skopecek
L. Spinarova
L. Raclavska
R. Sarbochova
L. Okenka
E. Racicka
K. Urbancova
M. Oznerova
Z. Lorenc
B. Wasserburger
E. Zahumensky
H. Gruenfeldova
J. Hradec
M. Lukac
S. Svacina
J. Podzimek
L. Hemzsky
I. Mikulkova
J. Pavlickova
T. Brychta
J. Chochola
T. Couffinhal
M. Elbaz
C. Petit
B. Faller
R. Marechaud
P. Moulin
S. Fendri
P. Nazeyrollas
U. Wendisch
K. Busch
G. Klausmann
H. Duengen
K. Appel
N. Toursarkissian
T. Jung
P. Ott
I. Schenkenberger
D. Kuesters
B. Landers
R. Nischik
H. Fischer
D. Tschoepe
B. Paschen
K. Krause
K. Derwahl
V. Wenzl-Bauer
A. Hamann
H. Strotmann
K. Milek
S. Mueller
K. Tan
C. Tsang
D. Chu
B. Tomlinson
K. Kung
L. Koranyi
Z. Kerenyi
B. Benczur
L. Illyes
T. Hidvegi
A. Somogyi
J. Valco
S. Ferenczi
J. Rapi
P. Voeroes
G. Winkler
T. Sydo
M. Hetey
K. Simon
J. Penzes
P. Kempler
B. Bako
Z. Lengyel
I. Witmann
M. Dudas
G. Vandorfi
J. Takacs
A. Matoltsy
E. Ladanyi
A. Gyimesi
S. Sadikot
K. Parikh
S. Jain
C. Yajnik
A. Sosale
P. Shamanna
S. Srikanta
S. Shah
A. Srinivas
D. Banker
P. Shah
A. Sharda
B. Makkar
N. Desai
N. Rais
H. Mardikar
A. Mishra
S. Bhupati
J. Menon
S. Sathe
R. Gupta
V. Sharma
M. Darawsha
T. Herskovits
S. Hamoud
E. Nikolsky
F. Adawi
D. Tsalihin
J. Wainstein
E. Klainman
M. Mosseri
Y. Yerushalmi
E. Karnieli
H. Knobler
R. Zimlichman
S. Benchetrit
A. Tsur
Y. Yagil
S. Atar
I. Beberashvili
S. Fuchs
N. Stern
A. Pollak
T. Chajek-Shaul
Y. Rozenman
A. Biton
E. Bramucci
A. Fiscella
V. Grassia
P. Piatti
S. De Cosmo
L. Di Lorenzo
P. Merlini
E. Mannucci
S. Frontoni
R. Trevisan
L. Zenari
C. Lambiase
A. Salvioni
O. Silvestri
G. Ambrosio
P. Di Bartolo
L. Fattore
P. Presbitero
M. Calabrese
R. Evola
M. Alcocer Gamba
M. Odin de los Rios Ibarra
E. Cardona Munoz
D. Reyes Sanchez
C. Hernandez Herrera
J. Perez Rios
E. Bayram Llamas
G. Llamas Esperon
E. Garcia Cantu
J. Nunez Fragoso
J. Gonzalez Gonzalez
G. Rivera Martinez
F. Padilla Padilla
G. Melendez Mier
D. Herrera Marmolejo
J. Garza Ruiz
N. Caracas Portilla
E. Lopez Rosas
G. Mendez Machado
J. Chevaile Ramos
I. Rodriguez Briones
M. W. J. van Hessen
S. Strikwerda
S. H. K. The
A. Kooy
E. Ronner
P. R. Nierop
J. J. Remmen
B. E. Groenemeijer
B. J. B. Hamer
D. C. G. Basart
H. W. O. Roeters van Lennep
M. Nieuwdorp
M. P. M. van Dijk
S. Kentgens
W. W. van Kempen
J. Hoogendijk
W. Spiering
C. Voors-Pette
V. Kose
D. E. P. de Waard
F. Gonkel
H. A. H. Kaasjager
G. M. Rojas Lingan
I. Agous
H. J. Kruik
B. P. M. Imholz
M. Pieterse
H. Manrique
J. Villena
L. Leon
K. Kundert
J. Minchola
M. Pinto
J. Heredia
A. Rodriguez
C. Guerreros
P. Berrospi
C. Zubiate
A. Allemant
H. Arbanil
W. Ponciano
J. Calderon
R. Lisson
L. Segura
A. Sidorowicz-Bialynicka
R. Sciborski
I. Fares
P. Mader
J. Skierkowska
T. Stasinska
W. Pomiecko
M. Skorski
E. Krzyzagorska
M. Polaszewska-Muszynska
D. Sowinski
K. Strojek
J. Rosinska-Migda
P. Romanczuk
G. Golebiowski
J. Kubica
T. Mazurek
L. Wojnowski
D. Pasternak
P. Stachlewski
E. Trzepla
G. Bogdanowicz
A. Uzunow
I. Potakowska
Z. Miszczyszyn
T. Waszyrowski
O. Smolenskaya
Y. Lukyanov
N. Vorokhobina
Y. Khalimov
O. Orlikova
A. Rebrov
V. Kukharchuk
S. Boldueva
M. Arkhipov
T. Zhelninova
E. Pavlysh
M. Antsiferov
A. Panov
M. Pavlova
S. Shustov
E. Demchenko
A. Galyavich
E. Malakhina
O. Semenova
Z. Kobalava
S. Kotova
I. Gavrisheva
E. Oschepkova
Y. Karpov
B. Sidorenko
O. Kislyak
A. Ametov
A. Dreval
E. Grineva
A. Mkrtumyan
T. Tyurina
O. Sazonova
F. Bonnici
N. Ranjith
L. Burgess
H. Nortje
L. Distiller
I. Mitha
R. Moore
M. Conradie
A. Horak
S. Pillay
H. Wellmann
E. Berg
P. Pillai
T. Padayachee
C. Corbett
H. Makan
J. Wing
Z. Vawda
I. Ebrahim
A. Dalby
E. Mitha
A. Bhorat
J. Cruz Fernandez
C. Munoz
J. Bruguera Cortada
A. Castro Conde
C. Calvo
B. Gil Extremera
E. Delgado
L. Masmiquel
J. Garcia Puig
L. de Teresa Parreno
D. Mauricio
J. Redon
M. Brito
C. Lopez
J. Segura de la Morera
C. Linderfalk
H. Larnefeldt
A. Olsson
L. Lonneborg
M. Ekelund
B. Samad
B. Borgencrantz
J. Nilsson
O. Berglund
M. Svensson
T. Mooe
D. Curiac
J. Albin
E. Angesjo
O. Lannemyr
C. Chiang
W. Sheu
J. Chen
K. Tien
K. Ueng
W. Lai
W. Yin
Y. Hung
K. Shyu
J. Hou
H. Lam
P. Laothavorn
S. Kuanprasert
W. Khovidhunkit
Y. Benjasuratwong
C. Chotinaiwattarakul
S. Mamanasiri
S. Suraamornkul
T. Pratipanawatr
W. Nitiyanant
S. Heller
K. Ray
R. Pieters
C. Strang
B. Bodalia
A. Middleton
T. Hall
G. Chapman
J. Calvert
R. Reed
D. Tam
G. Butcher
N. Jones
A. Takhar
W. Turner
D. McNally
O. Corey
J. Chapman
S. Mohr
S. Edwards
D. Bhatt
J. Davidson
A. Ocampo
D. Kandath
Y. Aude
W. Ervin
V. Savin
R. Anderson
R. Littlefield
M. Oberoi
George E. Platt
S. Yazdani
R. Mangoo-Karim
J. Walder
H. Gogia
Y. Chandrashekhar
F. Boccalandro
W. Rogers
S. Bilazarian
F. Zieve
Y. Siage
T. O'Connor
S. Mudaliar
A. Nikas
R. Giusti
R. Glover
S. Chilka
W. French
E. Roth
N. Singh
R. Christofferson
M. Stich
S. Dagogo-Jack
J. Allison
G. Arroyo Zengotita
R. Ison
B. Iteld
M. Sulistio
E. Gonzalez
T. Gorman
E. Hage-Korban
R. Reddy
W. Byars
M. Antonishen
S. Benjamin
B. First
J. Rosado
H. Bruschetta
P. Mehta
T. Poling
C. Rosendorff
Howard J. Kerstein
F. Saba
J. Willis
K. Adams
E. Camilo Vazquez
H. Ellison
B. Kahn
D. Kereiakes
S. Powell
P. Raskin
K. Smith
S. Varma
F. Whittier
R. Casanova
S. Isserman
W. Kaye
W. McGuinn
A. Bartkowiak
L. Dworkin
Carlos A. Labrador
D. Podlecki
M. Popovtzer
S. Aronoff
C. Ballantyne
Elena Gonzalez-Ortiz
A. Mora
T. Pitts
S. Reinhardt
G. Soucie
W. Wainwright
B. Henson
N. Sklaver
R. Arakaki
J. Brown
G. Chalavarya
R. Chochinov
T. Dixon
M. Kutner
R. Perlman
A. Raisinghani
A. Salacata
V. Awasty
V. Elinoff
W. George
A. LaRochelle-Gryseels
A. Mercado
G. Miller
M. Qureshi
A. Steljes
F. Wefald
J. Wilson
J. Chinn
Rita B. Chuang
A. Comulada-Rivera
I. Hartman
P. Narayan
T. Pacheco
R. Weiss
J. Beavins
J. Creevy
G. Hamroff
R. Hodson
E. Kosinski
P. Krichmar
R. Patel
R. Schneider
J. Shapiro
D. Sharp
J. Speer
R. Stegemoller
F. Waxman
F. Young Chang
E. Braun
F. Eder
S. Minor
M. Albert
Kenneth W. Carr
B. Diaczok
I. Gastman
V. Gupta
K. Longshaw
J. M. Gonzalez-Campoy
M. Raikhel
J. Thomas
K. Wood
I. Diab
J. Furda
M. Gelernt
M. Halter
B. House
S. Kaster
G. Raad
R. Stamatin
B. Barker
R. Blonder
Robert J. Bloomberg
R. Burgos Calderon
A. Carrol
A. Comerota
M. Feinglos
D. Henderson
R. Kastelic
Larry D. Stonesifer
J. Talano
P. Ver Lee
J. Brosseau
W. Clark
E. Cohen
J. Fialkow
K. Horton
H. Kozman
J. McGill
C. Mihills
R. Poonawala
K. Shore
L. Tejada
R. Torres
W. Wright
G. Calatayud
H. Chandna
R. Drozdiak
R. Fink
R. Gill
M. Glandt
Daniel W. Gottlieb
T. Hack
J. Kay
V. Mansouri
T. McKnight
E. Mostel
L. Schmidt
H. Seide
E. Sonel
R. Taylor
M. Velasquez
E. Bretton
R. Feldman
A. Hartman
K. Hershon
Charles R. Leach
E. Martin
F. Mohiuddin
Y. Naygandhi
T. Riske
S. Schima
E. R. Uzoaga
H. Ward
R. Weinstock
T. Williams
A. Altschuller
T. Aoki
S. Blumenthal
A. Cash
Gilbert Eisner
J. Gutmann
M. Hagan
A. Kabour
T. Markus
W. McKenzie
M. Moursi
P. Mystkowski
F. Ovalle
R. Perkins
L. Popeil
R. Saniuk
Y. Sierra
O. Alvarado
J. Anderson
M. Bajaj
R. Blank
A. Chu
L. Levinsky
P. Levy
J. Osborne
H. Pavon
D. Sanderlin
G. Schaer
S. Zarich
K. Atassi
C. Bayron
M. Casagrande
D. Das
M. Gimness
F. Handel
T. Kinstrey
S. Leu
K. Osei
J. Soba Nouel
Z. Soltani
H. Sussman
K. Chiu
R. Duda
K. Farnsworth
M. Lano
F. Lee
P. Levin
S. Pratt
R. Richwine
L. Ruiz-Rivera
J. Turner
J. Wood
William D. Zigrang
Hernan R. Baquerizo
Carlos Benitez Colon
J. Demattia
V. Desai
D. Fitz-Patrick
S. Goral
A. Odhav
A. Prentiss
C. Ruff
W. Wu
K. Wyne
Lisa G. Abbott
R. Applegate
J. Cabral
P. Kotha
P. Ortega
D. Simmons
2013 NEW ENGLAND JOURNAL OF MEDICINE
14.0 (369.0), pp. 1317.0-1326.0
1581 0 0 0 0 0 1581
44. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions Nataporn Chaipichit
Janet Krska
Thongchai Pratipanawatr
Verawan Uchaipichat
Narumol Jarernsiripornkul
2014 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
5.0 (70.0), pp. 607.0-615.0
34 0 0 0 0 0 34
45. DIFFERENCES IN MORTALITY BY EDUCATION LEVEL AMONG PATIENTS IN DIABETIC REGISTRY FOR THAILAND Thongchai Pratipanawatr
Petch Rawdaree
Thanya Chetthakul
Pongamorn Bunnag
Chardpraorn Ngarmukos
Yupin Benjasuratwong
Rattana Leelawatana
Natapong Kosachunhanun
Nattachet Plengvidhya
Chaicharn Deerochanawong
Sompongse Suwanwalaikorn
Sirinate Krittiyawong
Sirima Mongkolsomlit
Chulaluk Komoltri
2015 SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH
1.0 (46.0), pp. 125.0-132.0
0 0 0 0 0 0 0
46. Experiences of adverse drug effects reported by patients in ambulatory clinic Narumol Jarernsiripornkul
Nataporn Chaipichit
Janet Krska
Verawan Uchaipichat
Thongchai Pratipanawatr
2015 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
1.0 (37.0), pp. 213.0-213.0
0 0 0 0 0 0 0
47. Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2015 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
1.0 (37.0), pp. 224.0-225.0
0 0 0 0 0 0 0
48. Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries Nataporn Chaipichit
Janet Krska
Thongchai Pratipanawatr
Narumol Jarernsiripornkul
2015 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
2.0 (37.0), pp. 355.0-364.0
20 2 0 0 0 0 22
49. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions Narumol Jarernsiripornkul
Nataporn Chaipichit
Thongchai Pratipanawatr
Verawan Uchaipichat
Janet Krska
2016 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
1.0 (25.0), pp. 54.0-63.0
6 0 0 0 0 0 6
50. Attitude towards usefulness of patient information leaflets among ambulatory patients Supawinee Pongpunna
Thongchai Pratipanawatr
Narumol Jarernsiripornkul
2018 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
1.0 (40.0), pp. 276.0-277.0
0 0 0 0 0 0 0
51. Confidence and accuracy in identification of adverse drug reactions reported by outpatients Sirinya Kampichit
Thongchai Pratipanawatr
Narumol Jarernsiripornkul
2018 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
6.0 (40.0), pp. 1559.0-1567.0
0 0 0 0 0 0 0
52. Survey of outpatients' use and needs of patient medicine information leaflets in Thailand Supawinee Pongpunna
Thongchai Pratipanawatr
Narumol Jarernsiripornkul
2019 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
1.0 (41.0), pp. 141.0-150.0
1 0 0 0 0 0 1
53. Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study) Young Min Cho
Chaicharn Deerochanawong
Samroeng Seekaew
Swangjit Suraamornkul
Sunun Benjachareonwong
Sarinya Sattanon
Parinya Chamnan
Thanitha Sirirak
Natapong Kosachunhanun
Thongchai Pratipanawatr
Sompongse Suwanwalaikorn
Woo Je Lee
Sungrae Kim
Seonghui Choi
Eun Seok Kang
Taekeun Oh
Sam Kwon
Moon-Kyu Lee
2020 DIABETES OBESITY & METABOLISM
1.0 (22.0), pp. 123.0-127.0
0 0 0 0 0 0 0

Title Authors Year Journal title
1. Updated Treatment for Osteoporosis Chatlert Pongchaiyakul
Choowong Pongchaiyakul
Thongchai Pratipanawatr
2004 Srinagarind Medical Journal
(19 No 2), pp. 79-94
2. Modified Thai Diabetes Risk Score as a Screening Tool For Identification Metabolic Syndrome Siwakorn Porntrakulphiphat
Kaewjai Thepsuthammarat
Tatiya Treapkhuntong
Thongchai Pratipanawatr
2011 Srinagarind Medical Journal
(26 No 3), pp. 213-224
3. Achievement in National Licensing Examination Steps I and II of Khon Kaen Medical Students from Various Programs Pranom Buppasiri
Piyathida Kuhiranratn
Chulapan Engchanil
Pungpayom Kaewpila
Sirinan Sila-on
Thongchai Pratipanawatr
2013 Srinagarind Medical Journal
(28 No 4), pp. 516-523
4. Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2014 Srinagarind Medical Journal
(29 No 5), pp. 461-468
5. Difference of Bone Mineral Density between Postmenopausal Women with and Without Metabolic Syndrome Siriruthai Amnatbuddee
Woraluck Somboonporn
Sukree Soontrapa
Srinaree Kaewrudee
Thongchai Pratipanawatr
2016 Srinagarind Medical Journal
(31 No 5), pp. 67

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ

0.02622365951538086